XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Mar. 31, 2023
Current assets:          
Cash and cash equivalents $ 8,589 $ 9,136   $ 8,608  
Other current assets 389 473   783  
Total current assets 8,978 9,609   9,391  
Long-term assets:          
Fixed assets, net 19 21   16  
Deferred offering costs 0 176   0  
Total long-term assets 19 197   16  
Total Assets 8,997 9,806   9,407  
Current liabilities:          
Accounts payable 815 676   492  
Accrued expenses 1,150 1,031   285  
Total current liabilities 1,965 1,707   777  
Total Liabilities 1,965 1,707   1,779  
Commitments and contingencies (Note 5)    
Stockholders' equity:          
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. 0 0   0  
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,497,033 and 942,575 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. 4 2   1  
Additional paid-in capital 60,744 58,476   46,596  
Accumulated deficit (53,716) (50,379)   (38,969)  
Total Stockholders' Equity 7,032 8,099 $ 5,289 7,628 $ 644
Total Liabilities and Stockholders' Equity $ 8,997 $ 9,806   $ 9,407